RxDoctor Payments DataLook up a doctor →

Wesley Calhoun, MD

Nephrology · San Antonio, TXNPI 1174508659

Payments from drug & device makers

$3,473,959in general payments, 2019–2025

Across 861 payments — averaging $4034.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • CSL Behring$2.5M
  • AstraZeneca$367K
  • Akebia Therapeutics Inc$232K
  • Otsuka Pharmaceutical Development & Commercialization, Inc.$101K
  • GSK$58K
  • Baxter Healthcare$57K
  • plus $141K from 32 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
CSL Behring116$2,517,384
AstraZeneca(2 entities)73$366,896
Akebia Therapeutics Inc291$231,893
Otsuka Pharmaceutical Development & Commercialization, Inc.3$100,575
GSK44$58,448
Baxter Healthcare6$57,434
Vertex5$49,518
Bayer22$47,128
Dynavax Technologies Corporation35$21,927
Novartis18$9,140
Ardelyx, Inc.9$8,522
Amgen(2 entities)45$901
Otsuka America Pharmaceutical, Inc.30$567
Aurinia Pharma U.S., Inc.20$506
Veloxis Pharmaceuticals, Inc.17$435
Calliditas Therapeutics US Inc.15$405
Vifor Pharma, Inc.18$355
Mallinckrodt Hospital Products Inc.14$317
Travere Therapeutics, Inc.19$294
Cormedix Inc.6$199
ANI Pharmaceuticals, Inc.8$189
Mallinckrodt Enterprises LLC11$168
Novo Nordisk5$111
Boehringer Ingelheim4$79
Ultragenyx Pharmaceutical Inc.3$68
Johnson & Johnson3$67
Amicus Therapeutics, Inc.3$65
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC4$57
Sanofi1$55
Takeda Pharmaceuticals U.S.A., Inc.2$47
Lilly USA, LLC2$40
OPKO Pharmaceuticals, LLC2$35
Fresenius USA Marketing, Inc.2$33
Kyowa Kirin, Inc.1$25
Alnylam Pharmaceuticals Inc.1$24
Leadiant Biosciences, Inc.1$21
Recordati_rare_diseases_inc.1$19
Arbor Pharmaceuticals, Inc.1$13

How this compares

$3,473,959 in reported general payments places this provider in the 95th percentile of 1,070 nephrology providers in Texas.

See all nephrology providers in Texas →

Medicare billing

Part B allowed, 2024
$192,735
Medicare patients
398
Services billed
2,383

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other nephrology in San Antonio

See the full list for Texas →

Where these figures come from

Is this you, or does something look wrong? →